Regencell Bioscience Holdings Limited
Hedge Funds Holdings
Last updated:
Regencell Bioscience Holdings Limited‘s stocks are currently a part of 5 hedge funds’ portfolios, which represents 0.09% of the total amount of its stocks outstanding. This makes up a total of 8.49K shares of Regencell Bioscience Holdings Limited. Compared to the previous quarter, the number fell by -58.02% or -11.74K shares fewer. As for the holding position changes, 40% (2) of current hedge fund investors increased the number of shares held, and 40% (2) closed the holdings completely. 3 hedge funds are new holders of Regencell Bioscience Holdings Limited stock in Q2 2022, it is 60% of total holders.
Hedge funds holding Regencell Bioscience Holdings Limited (Q1 2016 – Q2 2022)
Q1 2016 | 236 |
---|---|
Q2 2016 | 255 |
Q3 2016 | 239 |
Q4 2016 | 285 |
Q1 2017 | 267 |
Q2 2017 | 257 |
Q3 2017 | 251 |
Q4 2017 | 270 |
Q1 2018 | 3 |
Q2 2018 | 0 |
Q2 2020 | 1 |
Q3 2020 | 0 |
Q4 2020 | 0 |
Q3 2021 | 3 |
Q4 2021 | 2 |
Q1 2022 | 4 |
Q2 2022 | 5 |
Hedge funds changes in Regencell Bioscience Holdings Limited positions (Q1 2016 – Q2 2022)
Q1 2016 | 32 | 82 | 88 | 35 | -1 |
---|---|---|---|---|---|
Q2 2016 | 45 | 100 | 77 | 23 | 10 |
Q3 2016 | 26 | 91 | 85 | 39 | -2 |
Q4 2016 | 70 | 110 | 69 | 21 | 15 |
Q1 2017 | 38 | 91 | 96 | 50 | -8 |
Q2 2017 | 36 | 119 | 72 | 44 | -14 |
Q3 2017 | 57 | 91 | 78 | 59 | -34 |
Q4 2017 | 89 | 66 | 86 | 68 | -39 |
Q1 2018 | 1 | 0 | 0 | 266 | -264 |
Q2 2018 | 0 | 0 | 0 | 3 | -3 |
Q2 2020 | 1 | 0 | 0 | 0 | 0 |
Q3 2020 | 0 | 0 | 0 | 1 | -1 |
Q4 2020 | 0 | 0 | 0 | 1 | -1 |
Q3 2021 | 3 | 0 | 0 | 0 | 0 |
Q4 2021 | 2 | 0 | 0 | 3 | -3 |
Q1 2022 | 3 | 1 | 0 | 1 | -1 |
Q2 2022 | 3 | 2 | 0 | 2 | -2 |
Hedge funds changes in Regencell Bioscience Holdings Limited stock options (Q1 2016 – Q2 2022)
Q1 2016 | 4,699,000 | 3,485,000 |
---|---|---|
Q2 2016 | 2,778,000 | 4,789,000 |
Q3 2016 | 928,000 | 455,000 |
Q4 2016 | 1,267,000 | 892,000 |
Q1 2017 | 2,094,000 | 1,456,000 |
Q2 2017 | 2,576,000 | 693,000 |
Q3 2017 | 7,397,000 | 10,572,000 |
Q4 2017 | 28,024,000 | 1,000,021,668,000 |
Q1 2018 | 0 | 0 |
Q2 2018 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 0 | 0 |
Q4 2020 | 0 | 0 |
Q3 2021 | 0 | 0 |
Q4 2021 | 0 | 0 |
Q1 2022 | 0 | 0 |
Q2 2022 | 0 | 0 |
Top 50 hedge fund holders of Regencell Bioscience Holdings Limited (NASDAQ:RGC)
Hedge fund | Value | Shares owned | Portfolio share |
---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 216K | 6.81K | 0.000% |
UBS GROUP AG | 17K | 548 | 0.000% |
TOWER RESEARCH CAPITAL LLC (TRC) | 12K | 372 | 0.000% |
BLACKROCK INC. Larry Fink | 8K | 238 | 0.000% |
MORGAN STANLEY | 7K | 221 | 0.000% |
VIRTUS FUND ADVISERS, LLC | 0 | 0 | 0.000% |